Pfizer | PFE

Stock Price
29.42
Daily Change
-0.03 -0.10%
Monthly
4.03%
Yearly
-23.88%
Q2 Forecast
28.52
Peers Price Chg Day Year Date
AbbVie 162.12 2.02 1.26% 18.46% Jun/04
Abbott 102.92 -0.47 -0.45% -0.81% Jun/05
ALKERMES 23.65 -0.41 -1.68% -19.72% Jun/04
Amgen 306.90 -0.50 -0.16% 38.73% Jun/05
AstraZeneca 12,519.00 115.00 0.93% 5.81% Jun/05
Bayer 28.69 0.36 1.25% -45.12% Jun/05
Biogen 233.01 3.48 1.52% -22.28% Jun/05
Bristol-Myers Squibb 41.45 -0.31 -0.74% -37.18% Jun/05
Catalent 54.97 0.81 1.50% 45.41% Jun/05
Gilead Sciences 63.88 -0.23 -0.36% -16.17% Jun/05
GlaxoSmithKline 1,658.00 43.00 2.66% 19.16% Jun/05
Glaxosmithkline 42.34 0.99 2.39% 23.51% Jun/05
J&J 147.51 -0.33 -0.22% -6.83% Jun/05
Eli Lilly 830.49 1.23 0.15% 86.94% Jun/05
Medtronic 82.94 -0.38 -0.46% -0.79% Jun/05
Merck 128.48 -0.10 -0.08% 16.79% Jun/05
Neurocrine Biosciences 133.48 -6.44 -4.60% 42.21% Jun/04
Novartis 94.12 1.39 1.50% 3.98% Jun/05
Novartis 105.53 0.63 0.60% 5.89% Jun/05
Prestige Brands 64.60 0.35 0.54% 14.78% Jun/05
Pacira 30.52 -0.37 -1.20% -20.83% Jun/04
Pfizer 29.42 -0.03 -0.10% -23.88% Jun/05
Perrigo 27.09 -0.07 -0.26% -19.27% Jun/05
Drreddys Laboratories 69.38 0.63 0.91% 22.98% Jun/05
Regeneron Pharmaceuticals 997.02 8.75 0.89% 32.89% Jun/05
Roche Holding 237.45 3.25 1.39% -18.72% Jun/05
Sanofi 91.13 0.86 0.95% -5.44% Jun/05
Sanofi 49.62 0.35 0.70% -3.63% Jun/05
Vertex Pharmaceuticals 474.98 0.04 0.01% 42.03% Jun/05
Zoetis 171.99 -0.43 -0.25% 0.51% Jun/04

Indexes Price Day Year Date
US500 5315 23.92 0.45% 24.08% Jun/05

Pfizer traded at $29.50 this Tuesday June 4th, increasing $0.17 or 0.58 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 4.31 percent. Over the last 12 months, its price fell by 23.67 percent. Looking ahead, we forecast Pfizer to be priced at 28.52 by the end of this quarter and at 28.01 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.